1-20 of 85
Carla Casulo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Understanding the Patient Perspective on Treatment Preferences for Follicular Lymphoma

Mazie Tsang, Urshila Durani, Jonathan R Day, Melissa C. Larson, Matthew Holets, Kathleen J Yost, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Peter Martin, Brad S. Kahl, Thomas M. Habermann, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Carla Casulo, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 7598.
https://doi.org/10.1182/blood-2024-210968
Published: 2024
Journal Articles

Outcomes in Early Relapse of Follicular Lymphoma Versus Early Histologic Transformation Following Firstline Immunochemotherapy in Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Jonathan R Day, Urshila Durani, Mazie Tsang, Jonathan W. Friedberg, Grzegorz S. Nowakowski, Jean L. Koff, Dai Chihara, Richard Burack, Thomas M. Habermann, Loretta Nastoupil, Izidore S. Lossos, Peter Martin, Matthew Holets, Brad S. Kahl, Jonathan J. Cohen, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 1652.
https://doi.org/10.1182/blood-2024-201078
Published: 2024
Journal Articles

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Patrizia Mondello, Brianna J Negaard, Andrew L. Feldman, Brian K. Link, Carla Casulo, Dai Chihara, David A Russler-Germain, Jason Romancik, Caitlin Gribbin, Sara Haddadi, Eric Mou, Ivana N. Micallef, Patrick B. Johnston, Anne J. Novak, Yucai Wang, Rebecca L. King, Thomas M. Habermann, Peter Martin, Grzegorz S. Nowakowski, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Matthew J. Maurer, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2024-194681
Published: 2024
Journal Articles

5-Year Follow-up Analysis from ZUMA-5: A Phase 2 Trial of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph D. Rosenblatt, Jacob Wulff, Rhine Shen, Wangshu Zhang, Soumya Poddar, Harry Miao, Olga Nikolajeva, Caron A. Jacobson
Journal: Blood
Blood (2024) 144 (Supplement 1): 864.
https://doi.org/10.1182/blood-2024-194627
Published: 2024
Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua Tobin, Loic Chartier, Brian K. Link, Andrew L. Feldman, Dai Chihara, Carla Casulo, Anne Ségolène Cottereau, Luca Guerra, Joshua Olson, Jason T Romancik, Sara Haddadi, Harrison Black, Thomas Trevis, Eric Mou, Tsz Hung Tong, Kamilia Moalem, Anna M. Johnston, Paul J. Hampel, Jeffrey Johnson, Steinepreis Elizabeth, Pinguang Yang, Serena Kosciejew, Goodall Elizabeth, Kate Manos, Chan Y. Cheah, Ross Salvaris, Thomas M. Habermann, Peter Martin, Brad S. Kahl, Grzegorz S. Nowakowski, Georgina Hodges, Loretta Nastoupil, Dipti Talaulikar, Judith Trotman, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Stefano Luminari, Franck Morschhauser, Stephen M. Ansell, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3007.
https://doi.org/10.1182/blood-2024-202088
Published: 2024
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results from the Phase 2 PRIMO Trial

Neha Mehta-Shah, Pier Luigi Zinzani, Eric D. Jacobsen, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppe Gritti, Lauren C. Pinter-Brown, Koji Izutsu, Ohad S Bentur, David Sidransky, Jonathan E. Brammer, Barbara Pro, Christopher P. Fox, Steven Horwitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2024-203577
Published: 2024
Journal Articles

Occurrence and Predictors of Patient Reported Fertility Discussions in Non-Hodgkin Lymphoma Patients: Utilizing the Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

Nadia Toumeh, Melissa C. Larson, Bri J Negaard, Carla Casulo, Sairah Ahmed, Matthew J. Maurer, Andrew L. Feldman, Brian K. Link, Jonathon B. Cohen, Thomas M. Habermann, Dai Chihara, Izidore S. Lossos, Jonathan W. Friedberg, Brad Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Annalynn M Williams, Allison C. Rosenthal, Carrie A Thompson, Urshila Durani
Journal: Blood
Blood (2024) 144 (Supplement 1): 3736.
https://doi.org/10.1182/blood-2024-211091
Published: 2024
Journal Articles

Reverse Morning Report: A Case-Based, Fellow-Lead, Curriculum for Internal Medicine Residents Rotating on the Inpatient Malignant Hematology Service

Danielle S Wallace, Craig Maguire, Jozal Moore, Frank Passero, Jr., John Mariano, Carla Casulo, Alec B O'Connor
Journal: Blood
Blood (2024) 144 (Supplement 1): 3819.
https://doi.org/10.1182/blood-2024-193677
Published: 2024
Journal Articles

Vulnerable Elders Survey (VES-13) and Longitudinal Analysis of Quality of Life in Indolent Non-Hodgkin Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N Noble, Carla Casulo, Carrie A Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle A.T. Hildebrandt, Kathleen J Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L. Jaye, Jon Tilburt, Ajay Major, Talal Hilal, Yucai Wang, Amber Koehler, Timothy G. Call, Sameer A. Parikh, Javier L. Munoz, Gita Thanarajasingam, Loretta Nastoupil, Grzegorz S. Nowakowski, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou C Dueck
Journal: Blood
Blood (2024) 144 (Supplement 1): 2345.
https://doi.org/10.1182/blood-2024-210594
Published: 2024
Journal Articles

Real-World Predictors of Financial Toxicity in Patients with Lymphoma

Syeda A Mina, Katherine E Smith, Ashley D Hickman, Melissa C. Larson, Brianna J Negaard, Brittany C Kimball, Matthew J. Maurer, Kathleen J Yost, Grzegorz S. Nowakowski, Izidore S. Lossos, Peter Martin, Jonathon B. Cohen, Brian K. Link, Brad S. Kahl, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Amylou C Dueck, Annalynn M Williams, Carla Casulo, Carrie A Thompson, Urshila Durani
Journal: Blood
Blood (2024) 144 (Supplement 1): 3754.
https://doi.org/10.1182/blood-2024-201896
Published: 2024
Journal Articles

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with R-GemOx: A Multi-Center Retrospective Cohort Study

Samuel Yamshon, Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos, Sara Haddadi, Michele D. Stanchina, Dai Chihara, Amy A. Ayers, Thomas M. Habermann, Yucai Wang, Arushi Khurana, Grzegorz S. Nowakowski, Tanner W Reicks, Umar Farooq, Brian K. Link, Jonathon B. Cohen, Peter Martin, Jia Li, Ashwini Shewade, Connie Lee Batlevi, Andrea Lo-Rossi, David Fox, Anthony Masaquel, Yong Mun, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Loretta Nastoupil
Journal: Blood
Blood (2024) 144 (Supplement 1): 3093.
https://doi.org/10.1182/blood-2024-208111
Published: 2024
Journal Articles

How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Danielle S. Wallace, Kah Poh Loh, Carla Casulo
Journal: Blood
Blood blood.2024024788.
https://doi.org/10.1182/blood.2024024788
Published: 2024
Journal Articles

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

Clinical Trials & Observations
Mitchell R. Smith, Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir S. Parekh, David T. Yang, Eric D. Hsi, Thomas Witzig, Sandeep Dave, David Scott, Curtis Hanson, Lale Kostakoglu Shields, Nizar Abdel-Samad, Carla Casulo, Nancy L. Bartlett, Paolo F. Caimi, Tareq Al Baghdadi, Kristie A. Blum, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2024) 144 (10): 1083–1092.
https://doi.org/10.1182/blood.2024023962
Published: 2024
Includes: Supplemental data
Journal Articles

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)

Clinical Trials & Observations
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Ronald Korn, Weixin Peng, Christine Lui, Jacob Wulff, Rhine Shen, Soumya Poddar, A. Scott Jung, Harry Miao, Sara Beygi, Caron A. Jacobson
Journal: Blood
Blood (2024) 143 (6): 496–506.
https://doi.org/10.1182/blood.2023021243
Published: 2024
Includes: Supplemental data
Journal Articles

How do you define treatment success in MZL?

Carla Casulo
Journal: Blood
Blood (2024) 143 (5): 382–383.
https://doi.org/10.1182/blood.2023022494
Published: 2024
Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N. Noble, Côme Bommier, Carla Casulo, Carrie Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle Hildebrandt, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Susan L. Slager, Andrew L. Feldman, David L Jaye, Jon Tilburt, J. C. C. Villasboas, Ajay Major, Priyanka A Pophali, Talal Hilal, Yucai Wang, Timothy G. Call, Amber Koehler, Javier L. Munoz, Gita Thanarajasingam, Paul J Hampel, Sameer A. Parikh, Loretta J. Nastoupil, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M Ansell, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 3761.
https://doi.org/10.1182/blood-2023-188382
Published: 2023
Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Christopher R. Flowers, Thomas M. Habermann, Thomas E. Witzig, Yucai Wang, Grzegorz S. Nowakowski, Andrew L. Feldman, Loretta J. Nastoupil, Dai Chihara, Richard Burack, Jonathan R Day, Urshila Durani, Peter Martin, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, James R. Cerhan, Matthew J. Maurer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2023-186684
Published: 2023
Journal Articles

Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

Côme Bommier, Mazie Tsang, Brie N. Noble, Carrie Thompson, Carla Casulo, Michelle Hildebrandt, Allison C. Rosenthal, Eric Mou, Urshila Durani, Annalynn M Williams, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L Jaye, Peter Martin, Jonathon B. Cohen, Dai Chihara, Izidore S. Lossos, Christopher Strouse, Brad S. Kahl, Thomas M. Habermann, Christopher R. Flowers, Amylou Constance Dueck, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2395.
https://doi.org/10.1182/blood-2023-187056
Published: 2023
Journal Articles

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study

Jia Ruan, Zhengming Chen, Melissa C. Larson, N. Nora Bennani, Danielle Wallace, Pamela B. Allen, David L Jaye, Jonathon B. Cohen, Luis Enrique Malpica Castillo, Francisco Vega, Giorgio Inghirami, Eric Mou, Carla Casulo, Neha Mehta-Shah, Peter Martin, Matthew J. Maurer, Brad S. Kahl, Izidore S. Lossos, James R. Cerhan, Christopher R. Flowers, Andrew L. Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3079.
https://doi.org/10.1182/blood-2023-180318
Published: 2023
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023